Oral budesonide in the treatment of chronic refractory pouchitis
Open Access
- 28 February 2007
- journal article
- clinical trial
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 25 (10) , 1231-1236
Abstract
SUMMARY: Background Pouchitis is the major long‐term complication after ileal‐pouch nal anastomosis for ulcerative colitis. Ten to 15% of patients develop a chronic pouchitis, either treatment responsive or treatment refractory.Aim To evaluate the efficacy of oral budesonide in inducing remission and improving quality of life in patients with chronic refractory pouchitis.Methods Twenty consecutive patients with active pouchitis, not responding after 1 month of antibiotic treatment were treated with budesonide controlled ileal release 9 mg/day for 8 weeks. Symptomatic, endoscopic and histological evaluations were undertaken before and after treatment according to Pouchitis Disease Activity Index. Remission was defined as a combination of Pouchitis Disease Activity Index clinical score of ≤2, endoscopic score of ≤1 and total Pouchitis Disease Activity Index score of ≤4. The quality of life was assessed with the Inflammatory Bowel Disease Questionnaire.Results Fifteen of 20 patients (75%) achieved remission. The median total Pouchitis Disease Activity Index scores before and after therapy were, respectively, 14 (range 9–16) and 3 (range 2–10) (P < 0.001). The median Inflammatory Bowel Disease Questionnaire score also significantly improved from 105 (range 77–175) to 180 (range 85–220) (P < 0.001).Conclusion Eight‐week treatment with oral budesonide appears effective in inducing remission in patients with active pouchitis refractory to antibiotic treatment in this open‐label study.Keywords
This publication has 23 references indexed in Scilit:
- Systematic review: the management of pouchitisAlimentary Pharmacology & Therapeutics, 2006
- J ileal pouch–anal anastomosis for chronic ulcerative colitis: complications and long-term outcome in 1310 patientsBritish Journal of Surgery, 1998
- Pouchitis following pelvic pouch operation for ulcerative colitisDiseases of the Colon & Rectum, 1996
- Pouchitis after ileal pouch-anal anastomosis for ulcerative colitis occurs with increased frequency in patients with associated primary sclerosing cholangitis.Gut, 1996
- A Comparison of Budesonide with Prednisolone for Active Crohn's DiseaseNew England Journal of Medicine, 1994
- Oral Budesonide for Active Crohn's DiseaseNew England Journal of Medicine, 1994
- Double-blind crossover trial of metronidazole versus placebo in chronic unremitting pouchitisDigestive Diseases and Sciences, 1994
- Pouchitis After Ileal Pouch-Anal Anastomosis: A Pouchitis Disease Activity IndexMayo Clinic Proceedings, 1994
- Incidence and Characteristics of Pouchitis in the Kock Continent Ileostomy and the Pelvic PouchScandinavian Journal of Gastroenterology, 1993
- Restorative proctocolectomy with ileal reservoir: pathological and histochemical study of mucosal biopsy specimens.Journal of Clinical Pathology, 1987